Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for suprachoroidal delivery. CoTx-101 represents a potential b ...
Dyno Therapeutics unveils best-in-class Dyno-bn8 AAV vector for muscle gene therapies, achieving therapeutic delivery with improved safety potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback